These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 8589015)
1. Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature. Hoffmann L; Möller P; Pedersen-Bjergaard J; Waage A; Pedersen M; Hirsch FR Ann Oncol; 1995 Oct; 6(8):781-8. PubMed ID: 8589015 [TBL] [Abstract][Full Text] [Related]
2. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Andersen MK; Christiansen DH; Jensen BA; Ernst P; Hauge G; Pedersen-Bjergaard J Br J Haematol; 2001 Sep; 114(3):539-43. PubMed ID: 11552977 [TBL] [Abstract][Full Text] [Related]
3. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript. Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486 [TBL] [Abstract][Full Text] [Related]
4. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. Mistry AR; Felix CA; Whitmarsh RJ; Mason A; Reiter A; Cassinat B; Parry A; Walz C; Wiemels JL; Segal MR; Adès L; Blair IA; Osheroff N; Peniket AJ; Lafage-Pochitaloff M; Cross NC; Chomienne C; Solomon E; Fenaux P; Grimwade D N Engl J Med; 2005 Apr; 352(15):1529-38. PubMed ID: 15829534 [TBL] [Abstract][Full Text] [Related]
5. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462 [TBL] [Abstract][Full Text] [Related]
6. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia. Snijder S; Mellink CH; van der Lelie H Cancer Genet Cytogenet; 2008 Jan; 180(2):149-52. PubMed ID: 18206542 [TBL] [Abstract][Full Text] [Related]
7. Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia. Mays AN; Osheroff N; Xiao Y; Wiemels JL; Felix CA; Byl JA; Saravanamuttu K; Peniket A; Corser R; Chang C; Hoyle C; Parker AN; Hasan SK; Lo-Coco F; Solomon E; Grimwade D Blood; 2010 Jan; 115(2):326-30. PubMed ID: 19884644 [TBL] [Abstract][Full Text] [Related]
8. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study. Slack JL; Arthur DC; Lawrence D; Mrózek K; Mayer RJ; Davey FR; Tantravahi R; Pettenati MJ; Bigner S; Carroll AJ; Rao KW; Schiffer CA; Bloomfield CD J Clin Oncol; 1997 May; 15(5):1786-95. PubMed ID: 9164186 [TBL] [Abstract][Full Text] [Related]
9. Understanding the molecular pathogenesis of acute promyelocytic leukemia. Lo-Coco F; Hasan SK Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012 [TBL] [Abstract][Full Text] [Related]
10. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature. Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558 [TBL] [Abstract][Full Text] [Related]
11. Pulsed-field gel electrophoresis analysis of retinoic acid receptor-alpha and promyelocytic leukemia rearrangements. Detection of the t(15;17) translocation in the diagnosis of acute promyelocytic leukemia. Xiao YH; Miller WH; Warrell RP; Dmitrovsky E; Zelenetz AD Am J Pathol; 1993 Nov; 143(5):1301-11. PubMed ID: 8238249 [TBL] [Abstract][Full Text] [Related]
12. Acute promyelocytic leukemia with t(15;17) following inhibition of DNA topoisomerase II. Pedersen-Bjergaard J Ann Oncol; 1995 Oct; 6(8):751-3. PubMed ID: 8589010 [No Abstract] [Full Text] [Related]
13. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature. Quesnel B; Kantarjian H; Bjergaard JP; Brault P; Estey E; Lai JL; Tilly H; Stoppa AM; Archimbaud E; Harousseau JL J Clin Oncol; 1993 Dec; 11(12):2370-9. PubMed ID: 8246025 [TBL] [Abstract][Full Text] [Related]
15. Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy. Linassier C; Barin C; Calais G; Letortorec S; Brémond JL; Delain M; Petit A; Georget MT; Cartron G; Raban N; Benboubker L; Leloup R; Binet C; Lamagnère JP; Colombat P Ann Oncol; 2000 Oct; 11(10):1289-94. PubMed ID: 11106118 [TBL] [Abstract][Full Text] [Related]
16. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors? Dissing M; Le Beau MM; Pedersen-Bjergaard J J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906 [TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukaemia and the t(15;17) translocation. Gillard EF; Solomon E Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621 [TBL] [Abstract][Full Text] [Related]